107 related articles for article (PubMed ID: 8884896)
1. A double-blind, placebo-controlled, crossover trial of oral vitamin C in erythropoietic protoporphyria.
Boffa MJ; Ead RD; Reed P; Weinkove C
Photodermatol Photoimmunol Photomed; 1996 Feb; 12(1):27-30. PubMed ID: 8884896
[TBL] [Abstract][Full Text] [Related]
2. A double-blind study of cysteine photoprotection in erythropoietic protoporphyria.
Mathews-Roth MM; Rosner B; Benfell K; Roberts JE
Photodermatol Photoimmunol Photomed; 1994 Dec; 10(6):244-8. PubMed ID: 7727280
[TBL] [Abstract][Full Text] [Related]
3. Protoporphyrin photosensitivity cannot be attenuated by oral N-acetylcysteine.
Bijlmer-Iest JC; Baart de la Faille H; van Asbeck BS; van Hattum J; van Weelden H; Marx JJ; Koningsberger JC
Photodermatol Photoimmunol Photomed; 1992-1993 Dec; 9(6):245-9. PubMed ID: 1343225
[TBL] [Abstract][Full Text] [Related]
4. Treatment of erythropoietic protoporphyria with hydroxyethylrutosides.
Schoemaker JH; Bousema MT; Zijlstra H; van der Horst FA
Dermatology; 1995; 191(1):36-8. PubMed ID: 8589480
[TBL] [Abstract][Full Text] [Related]
5. Effects of Oral Vitamin C Supplementation on Anxiety in Students: A Double-Blind, Randomized, Placebo-Controlled Trial.
de Oliveira IJ; de Souza VV; Motta V; Da-Silva SL
Pak J Biol Sci; 2015 Jan; 18(1):11-8. PubMed ID: 26353411
[TBL] [Abstract][Full Text] [Related]
6. Oral vitamin C and endothelial function in smokers: short-term improvement, but no sustained beneficial effect.
Raitakari OT; Adams MR; McCredie RJ; Griffiths KA; Stocker R; Celermajer DS
J Am Coll Cardiol; 2000 May; 35(6):1616-21. PubMed ID: 10807468
[TBL] [Abstract][Full Text] [Related]
7. Long-term treatment of erythropoietic protoporphyria with cysteine.
Mathews-Roth MM; Rosner B
Photodermatol Photoimmunol Photomed; 2002 Dec; 18(6):307-9. PubMed ID: 12535027
[TBL] [Abstract][Full Text] [Related]
8. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9.
Age-Related Eye Disease Study Research Group
Arch Ophthalmol; 2001 Oct; 119(10):1439-52. PubMed ID: 11594943
[TBL] [Abstract][Full Text] [Related]
9. A double-blind placebo-controlled trial of antioxidant therapy in limited cutaneous systemic sclerosis.
Herrick AL; Hollis S; Schofield D; Rieley F; Blann A; Griffin K; Moore T; Braganza JM; Jayson MI
Clin Exp Rheumatol; 2000; 18(3):349-56. PubMed ID: 10895372
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D deficiency in patients with erythropoietic protoporphyria.
Spelt JM; de Rooij FW; Wilson JH; Zandbergen AA
J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S1-4. PubMed ID: 24137761
[TBL] [Abstract][Full Text] [Related]
11. Does vitamin C supplementation influence the levels of circulating oxidized LDL, sICAM-1, sVCAM-1 and vWF-antigen in healthy male smokers?
Van Hoydonck PG; Schouten EG; Manuel-Y-Keenoy B; van Campenhout A; Hoppenbrouwers KP; Temme EH
Eur J Clin Nutr; 2004 Dec; 58(12):1587-93. PubMed ID: 15127090
[TBL] [Abstract][Full Text] [Related]
12. Faster plasma vitamin E disappearance in smokers is normalized by vitamin C supplementation.
Bruno RS; Leonard SW; Atkinson J; Montine TJ; Ramakrishnan R; Bray TM; Traber MG
Free Radic Biol Med; 2006 Feb; 40(4):689-97. PubMed ID: 16458200
[TBL] [Abstract][Full Text] [Related]
13. Protective effect against sunburn of combined systemic ascorbic acid (vitamin C) and d-alpha-tocopherol (vitamin E).
Eberlein-König B; Placzek M; Przybilla B
J Am Acad Dermatol; 1998 Jan; 38(1):45-8. PubMed ID: 9448204
[TBL] [Abstract][Full Text] [Related]
14. Oral antioxidant supplementation for fatigue associated with primary biliary cirrhosis: results of a multicentre, randomized, placebo-controlled, cross-over trial.
Prince MI; Mitchison HC; Ashley D; Burke DA; Edwards N; Bramble MG; James OF; Jones DE
Aliment Pharmacol Ther; 2003 Jan; 17(1):137-43. PubMed ID: 12492743
[TBL] [Abstract][Full Text] [Related]
15. Topical ascorbic acid on photoaged skin. Clinical, topographical and ultrastructural evaluation: double-blind study vs. placebo.
Humbert PG; Haftek M; Creidi P; Lapière C; Nusgens B; Richard A; Schmitt D; Rougier A; Zahouani H
Exp Dermatol; 2003 Jun; 12(3):237-44. PubMed ID: 12823436
[TBL] [Abstract][Full Text] [Related]
16. Combination oral antioxidant supplementation reduces blood pressure.
Galley HF; Thornton J; Howdle PD; Walker BE; Webster NR
Clin Sci (Lond); 1997 Apr; 92(4):361-5. PubMed ID: 9176034
[TBL] [Abstract][Full Text] [Related]
17. Beta carotene therapy for erythropoietic protoporphyria and other photosensitivity diseases.
Mathews-Roth MM; Pathak MA; Fitzpatrick TB; Harber LH; Kass EH
Arch Dermatol; 1977 Sep; 113(9):1229-32. PubMed ID: 900968
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant supplementation for lung disease in cystic fibrosis.
Ciofu O; Lykkesfeldt J
Cochrane Database Syst Rev; 2014 Aug; (8):CD007020. PubMed ID: 25102015
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietic protoporphyria in the U.K.: clinical features and effect on quality of life.
Holme SA; Anstey AV; Finlay AY; Elder GH; Badminton MN
Br J Dermatol; 2006 Sep; 155(3):574-81. PubMed ID: 16911284
[TBL] [Abstract][Full Text] [Related]
20. Treatment of erythropoietic protoporphyria with N-acetylcysteine.
Norris PG; Baker CS; Roberts JE; Hawk JL
Arch Dermatol; 1995 Mar; 131(3):354-5. PubMed ID: 7887671
[No Abstract] [Full Text] [Related]
[Next] [New Search]
